GLUCOSE MONITORING METHOD AND DEVICE FOR TREATING HUMANS

• US 20120277563A1
• Filed: 04/26/2012
• Published: 11/01/2012
• Est. Priority Date: 04/27/2011
• Status: Abandoned Application

• Current Assignee: Alan G. Balu
• Original Assignee: Alan G. Balu
• Inventors: Balu, Alan G.
• Application Number:
  US13/456,905
• Publication Number:
  US 20120277563A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/7275 Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

This invention relates to a monitoring and/or stabilizing glucose level in the blood stream in a human body signaling the person in the event glucose is at a dangerous level, said method comprising the following steps:

• • (A) implanting a device in the human body wherein a tube from said device is inserted into a blood vessel and in the blood stream of a person;
  • (B) continuously monitoring said glucose level in the blood stream with said implanted device, at a set frequency of time;
  • (C) signaling said person in the event the glucose level drops below a specific level;
  • (D) optionally injecting, at least once, a specified dose of glucagon from a glucagon reservoir, into the subcutaneous tissue of said person;
  • (E) alerting medical providers when the glucose level remains below said specific level for at least two consecutive measurements of said glucose level in the blood stream; provided said signal is not manually silenced by the person.

Claims

1. A method for monitoring and/or stabilizing glucose level in the blood stream in a human body signaling the person in the event glucose is at a dangerous level, said method comprising the following steps:

(A) implanting a device in the human body wherein a tube from said device is inserted into a blood vessel and in the blood stream of a person;

(B) continuously monitoring said glucose level in the blood stream with said implanted device, at a set frequency of time;

(C) signaling said person in the event the glucose level drops below a specific level;

(D) optionally injecting, at least once, a specified dose of glucagon from a glucagon reservoir, into the subcutaneous tissue of said person;

(E) alerting medical providers when the glucose level remains below said specific level for at least two consecutive measurements of said glucose level in the blood stream;

provided said signal is not manually silenced by the person.

2. The method as recited in claim 1, wherein said specific level of glucose is 50.

3. The method as recited in claim 1, wherein said person whose glucose level being monitored has a receiving device that comprises a display for the glucose level and the time when the glucose level was measured, and an alarm mechanism to alert said person if the glucose level falls below a specified level.

4. The method as recited in claim 1, wherein the device contains a computer means that records information comprising the glucose level and the time the level is determined;

sends such information to a read-out means worn by the person;

signals the person when the glucose level is below a specific level, and in the event the level remains below said specific level, optionally actuates the device to inject a dose of glucagon; and

sends a signal to a medical authority.

5. The method as recited in claim 4, wherein the computer means comprises a computer chip and records in the computer chip are accessible and can be downloaded via a computer program.

6. The method as recited in claim 1, wherein said glucagon reservoir is covered by a septum wherein glucagon is replenished by an injection of glucagon through said septum when required.

7. The method as recited in claim 1, wherein said septum is a one-way septum.

8. A device for monitoring and/or stabilizing glucose level in the blood stream in a human body, wherein said device can be implanted into said human body, comprising:

(A) an enclosure capable of being implanted into said human body;

(B) a means attached to said enclosure for insertion into a blood vessel for monitoring said glucose level in the blood stream;

(C) a glucagon reservoir positioned in the enclosure, wherein said glucagon is injected into the blood stream in the event said glucose level drops below a specific level;

(D) an injector means connected to said enclosure for said glucagon;

(E) a computer means positioned in said enclosure that records information comprising said glucose level and the time the level is determined, wherein said computer means sends such information to a read-out means worn by a person, signaling said person when said glucose level is below a specific level, and in the event said level remains below said specific level, signaling medical authority, and optionally being connected to the injector means capable of actuating to inject a dose of glucagon into the blood stream.

9. The device as recited in claim 8, wherein said specific level of glucose is 50.

10. The device as recited in claim 8, further comprising a septum covering said reservoir, whereby said glucagon in said reservoir is replenished by injection of additional glucagon through said septum.

11. A read-out means, worn by said person in conjunction with said device as recited in claim 8, that records the glucose levels and the time the levels were determined and that signals said person when said glucose level is below a specific level.